Psychiatric symptoms are heterogeneousand differ in origin, structure and clinical expression. These differences are frequently ignored both clinically and in research. Thus, patients may be described as being anxious or as having delusions, with little realisation that different aspects of the structure of symptoms are being depicted. Neglect of differences in structure between symptoms has also naturally resulted in the neglect of differences in structure between superficially ‘same’ symptoms. A model is offered here which provides a means of classifying heterogeneity on the basis of five levels of clinical differentiation which, in turn, carries implications for underlying symptom structure. At the 1st level, symptoms can be differentiated in terms of the conventional category ‘form’ but which is in fact a composite of criteria. At the 2nd level, symptoms may be separated by differences in diagnosis which may alter structure; it is suggested that one way of capturing these is to assess the qualitative dimensions of the form. At the 3rd level, differentiation can occur on the basis of sensory modality, and, using hallucinations as an illustration, it has been shown that this is a weak and confused criterion. At the 4th level, symptoms can be differentiated on the basis of abstract criteria, often of historical origin, for which there is little empirical evidence. At the 5th level, the main criterion is difference in content. That not all symptoms will be susceptible to a fivefold analysis reinforces the argument that symptoms are structurally different and that these differences have psychometric and research implications.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.